Optimind Pharma Corp. (CSE:OMND)

Market Cap	1.03M
Revenue (ttm)	118.37K
Net Income (ttm)	-215.81K
Shares Out	102.79M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,108
Average Volume	2,255
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0100
52-Week Range	0.0050 - 0.0100
Beta	0.16
RSI	53.32
Earnings Date	Jun 27, 2025

About Optimind Pharma

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: David Goodman
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OMND

Financial Performance

In 2024, Optimind Pharma's revenue was 118,368, a decrease of -3.73% compared to the previous year's 122,959. Losses were -215,812, -84.56% less than in 2023.